Printer Friendly

ICN BIOMEDICALS REPORTS FIRST QUARTER EARNINGS OF 5 CENTS A SHARE

 COSTA MESA, Calif., May 11 /PRNewswire/ -- ICN Biomedicals Inc. (AMEX: BIM) today reported earnings in the first quarter of 1993 of $1 million, or 5 cents a share, on worldwide sales of $16 million.
 This compares to a net loss of $781,000, or 5 cents a share, on sales of $21 million in the first quarter of 1992.
 Earnings benefited from the continued reduction of operating expenses, including consolidation of the company's East Coast distribution into one facility in Aurora, Ohio, and continued consolidation of its European operations. ICN Biomedicals' gross profit margin was 53 percent in the first quarter of 1993, compared to 46 percent in the same period in 1992.
 Sales of the company's core products were up in the first quarter of 1993, including increases in sales of radioisotopes, biochemicals and cell biology products in France, Germany and the United Kingdom, and radioisotopes in the United States.
 In early 1993, ICN Biomedicals announced a new line of instrumentation products for diagnostic and research laboratories. Also, it received U.S. Food and Drug Administration authorization to market non-isotopic test kits for laboratories to detect thyroid disfunction and to monitor fertility disorders.
 ICN Biomedicals, one of the world's leading suppliers of biotechnology research products and medical diagnostics, sells more than 55,000 products to customers in more than 130 nations.
 ICN BIOMEDICALS INC.
 Summary Financial Information
 For the three months ended March 31, 1993 and 1992
 (Unaudited) (Amounts in thousands)
 Three months ended
 March 31,
 1993 1992
 Sales $15,809 $21,222
 Net income (loss) 1,016 (781)
 Net income (loss) per share $0.05 ($0.05)
 -0- 5/11/93
 /CONTACT: Paul Knopick of ICN Biomedicals, 714-545-0100, ext. 2465/
 (BIM)


CO: ICN Biomedicals Inc. ST: California IN: MTC SU: ERN

JL-BP -- LA037 -- 7284 05/11/93 17:47 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 11, 1993
Words:302
Previous Article:HILL AND KNOWLTON NAMES DICK BRODRICK SENIOR VICE PRESIDENT
Next Article:BALLISTIVET REPORTS FIRST QUARTER RESULTS
Topics:


Related Articles
ICN BIOMEDICALS REPORTS FIRST QUARTER RESULTS
ICN BIOMEDICALS REPORTS SECOND QUARTER RESULTS
ICN BIOMEDICALS REPORTS THIRD QUARTER RESULTS
ICN BIOMEDICALS INC. ANNOUNCES FIRST QUARTER DIVIDEND
ICN BIOMEDICALS ANNOUNCES YEAR-END RESULTS
ICN BIOMEDICALS INC. ANNOUNCES SECOND QUARTER DIVIDEND
ICN BIOMEDICALS REPORTS SECOND QUARTER EARNINGS INCREASE
ICN BIOMEDICALS REPORTS THIRD CONSECUTIVE QUARTER OF PROFITABILITY; DEBT SIGNIFICANTLY REDUCED
ICN BIOMEDICALS, INC. DECLARES DIVIDEND
ICN Acquires Cappel Immunobiological Product Division From Organon Teknika Corp.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters